Rational Money

Finding what the market misprices.

New deep dive →

[Rational Money @RationalMoneyX]

$ATAI $DFTX $CMPS $JNJ
The scalability gap in psychedelic medicine, in one chart.

[Rational Money @RationalMoneyX]

Q2 is over and $ATAI has not yet announced a partnership for BPL-003. I am starting to believe that there may be no more deal coming (at least not in the near future).

A deal would have infused the company with cash, which could've have funded not just the ongoing trials for BPL-003, VLS-01 and EMP-01, but also a potential diversification into other indications of the mental health market (PTSD, MDD, Alzheimers etc.).

On top of that, there would be a kind of guarantee for no further dilution in the future.

This would've made $ATAI the most diversified, best funded as well as most scalable psychedelic company, with a big pharmaceutical company on its side.

I still believe $ATAI is the best positioned company in this space, even with no deal happening. Anyway, I would be interested in how these talks developed and what made them walk away in the end.

Now with "just" around $200 Million cash on hand, I lack the creativity to see how they won't need further dilution sometime in 2028/29. They say that the current amount is enough to fund the company into early 2029 but this doesn't include the money needed to scale the product once it officially hits the market.

I could be wrong though, and maybe the talks are still ongoing but the current lack of transparency makes it hard to say.

[Rational Money @RationalMoneyX]

Currently doing a lot of research into $ENHA and really enjoyed this interview.

Takes just around 35 minutes and helps to understand the business and where it is going so much better.

[Michael, CPA @MacGillivrayCPA]

WATCH: @InTheAssembly landed an EXCLUSIVE interview with @enhanced_games Co-Founder and Executive Chairman, @C_Angermayer.

Listen to his thoughts on the recent inaugural Enhanced Games and where the telehealth business $ENHA is headed from here.

Skip to 2:00 for the interview.

[Rational Money @RationalMoneyX]

I started my first position in $ENHA today.

Was thinking about it for some weeks now. The current prices are just too tempting.

You don't even need to be a fan of their games but the whole peptide trend, which I expect to exponentially increase in the coming years, is reason enough for an investment.

Currently sitting at $400 Million Market Cap.

[Rational Money @RationalMoneyX]

@JackPrescottX How about $ATAI and $ENHA?

[Rational Money @RationalMoneyX]

@MultibaggerRsch Also just started my first position. The current risk reward setup is just too tempting.

[Rational Money @RationalMoneyX]

@BreakoutBiotech @NSistovaris Could also be the case. Should a partnership ever materialise, I would expect $ATAI to branch out into other indications anyway. So maybe it's a combination of all of the above: Partnership deal, Phase 3 initiation and new indications. Nevertheless, very exciting months ahead!

[Rational Money @RationalMoneyX]

@BreakoutBiotech @NSistovaris I am speculating that they may want to combine the announcement of BPL-003 Phase 3 initiation with a partnership deal. I could be completely wrong. But otherwise I see no reason why they haven't already announced the start of phase 3 via a press release.

[Brandon Richard @BreakoutBiotech]

$ATAI AtaiBeckley to be added to the Russell 2000 Index and the broad-market Russell 3000 Index. This follows recent additions to the S&P Total Market Index, S&P Completion Index, and CRSP U.S. benchmark indexes earlier this year.

"Joining the Russell Indexes - which collectively benchmark approximately $12.2 trillion in assets - represents another meaningful milestone for AtaiBeckley as we continue to expand our presence across the U.S. equity benchmark landscape, and increase visibility with a broad base of institutional investors. With our Phase 3 study of BPL-003 advancing, this development comes at an important time for the Company and reflects the maturity and strength of both our team and our late-stage mental health pipeline." — CEO Srinivas Rao

[Rational Money @RationalMoneyX]

@ataibeckley The redomiciliation to the US is really paying off!

[Rational Money @RationalMoneyX]

@otigart Have you looked into $ATAI yet? The psychedelic sector is really compelling right now.

[Rational Money @RationalMoneyX]

@hypergrowth102 I am thinking about initiating a position. But I also like $ATAI at current levels.

[Rational Money @RationalMoneyX]

@jrouldz Congrats. Got out of $DFTX with 300% a couple of months ago and reallocated it into $ATAI. Very excited for the future of psychedelics!

[Rational Money @RationalMoneyX]

Great news from $DFTX this morning.
Expecting a "rising tide lifts all boats" scenario and therefore believe that $ATAI will profit from today's news. The more publicity this sector gets, the better for all.

And also, $ATAI is confirmed to be included in the Russell Index with the upcoming Reconstitution. (see picture below).

[Rational Money @RationalMoneyX]

@C_Angermayer Who doesn't like being early, right?

[AbCellera @AbCelleraBio]

Jazz Pharmaceuticals and AbCellera Announce Collaboration to Discover Next-Generation T-cell Engaging Multispecific Antibodies https://t.co/ISSSHSyPVz

[Rational Money @RationalMoneyX]

@ThomasSchu12813 @retail_mourinho @CKCapitalxx Deal mit big pharma für BPL-003?

[Rational Money @RationalMoneyX]

$ATAI held talks with the FDA to expedite the BPL-003 Phase 3 Program. This has not yet been publicly disclosed due to "competitive reasons" according to CEO Srinivas Rao, speaking at the Jefferies Global Healthcare Conference 2026.

This would pull the currently expected topline readout, due in early 2029, forward to an earlier date.

[Rational Money @RationalMoneyX]

$ATAI initiated the BPL-003 Phase 3 program today according to CEO Srinivas Rao, speaking at the Jefferies Global Healthcare Conference 2026.

[Rational Money @RationalMoneyX]

For anyone just getting into psychedelic stocks like $DFTX, $ATAI, $GHRS, $CMPS and $HELP
I highly recommend you my sector overview that I've published just a few weeks ago:

https://t.co/Ld38fZY55E